{
    "organizations": [],
    "uuid": "bbc154b80b3fef3740789ebe677c6e41a1cd42b1",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-medtronic-receives-fda-approval-fo/brief-medtronic-receives-fda-approval-for-deep-brain-stimulation-therapy-for-type-of-epilepsy-idUSASC09YL4",
    "ord_in_thread": 0,
    "title": "BRIEF-Medtronic Receives FDA Approval For Deep Brain Stimulation Therapy For Type Of Epilepsy",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 1 (Reuters) - Medtronic PLC:\n* MEDTRONIC RECEIVES FDA APPROVAL FOR DEEP BRAIN STIMULATION THERAPY FOR MEDICALLY REFRACTORY EPILEPSY\n* MEDTRONIC PLC - FDA APPROVAL IS BASED ON BOTH BLINDED PHASE AND 7-YEAR FOLLOW-UP DATA COLLECTED IN COâ€™S CLINICAL TRIAL CALLED SANTE Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-01T20:07:00.000+03:00",
    "crawled": "2018-05-02T15:46:37.107+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "medtronic",
        "plc",
        "medtronic",
        "receives",
        "fda",
        "approval",
        "deep",
        "brain",
        "stimulation",
        "therapy",
        "medically",
        "refractory",
        "epilepsy",
        "medtronic",
        "plc",
        "fda",
        "approval",
        "based",
        "blinded",
        "phase",
        "data",
        "collected",
        "co",
        "clinical",
        "trial",
        "called",
        "sante",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}